NEAUA Main Site | Past & Future Meetings  
The New England Section of the American Urological Association
Meeting
Home
Accreditation
Information
Preliminary
Program
Registration
Information
Housing & Travel
Information
Exhibitors &
Sponsors
Local Area
Attractions
2017 Program and Abstracts
WEDNESDAY, SEPTEMBER 6, 2017
3:00 pm - 6:00 pm PEER REVIEW SEMINAR *Separate Registration Required
Salon Bonaventure
THURSDAY, SEPTEMBER 7, 2017
7:00 am - 5:00 pm REGISTRATION DESK
Inscription
7:00 am - 5:00 pm SPEAKER READY ROOM
St. Lambert
8:00 am - 8:20 am INTRODUCTION & WELCOME
Westmount & Outremont

Robert C. Flanigan, MD, FACS
AUA President-Elect

Richard K. Babayan, MD
AUA Past President
8:20 am - 9:50 am SCIENTIFIC SESSION I: PEDS SESSION
Westmount & Outremont (6 minute presentation, 2 minute discussion)
Moderators: Richard S. Lee, MD; Liza M. Aguiar, MD
8:20 am - 8:28 am 1. A Single Institution Experience of Complete Primary Repair of Bladder Exstrophy in Girls: Risk Factors for Urinary Retention
Bryan Sack, MD; Joseph Borer, MD
Boston Children's Hospital, Boston, MA
8:28 am - 8:36 am 2. Continuous Antibiotic Prophylaxis for Urinary Tract Infections in Prenatal Hydronephrosis: A Systematic Review and Meta-Analysis
Bethany Easterbrook, B.Kin1; Derek M. Bos, MD1; Katey Savage, BSc1; J P. Capolicchio, MD2; Armando J. Lorenzo, MD3; Luis H. Braga, MD1
1McMaster University, Hamilton, ON, Canada; 2Montreal Children's Hospital, Montreal, QC, Canada; 3The Hospital for Sick Children, Toronto, ON, Canada
8:36 am - 8:44 am 3. Endothelialization of a 3D Tissue-Engineered Human Vaginal Mucosa for Implantation
Weronika Jakubowska, MD-MSc Student; Stéphane Chabaud, PhD; Ingrid Saba, PhD; Stéphane Bolduc, MD
LOEX/ Université Laval, Quebec, QC, Canada
8:44 am - 8:52 am 4. A Contemporary Series Comparing Perioperative Outcomes Following Robotic Partial Nephrectomy to Open Partial Nephrectomy in Pediatric Patients with Poorly Functioning Renal Moieties
Archana Rajender, MD; Briony K. Varda, MD; Joseph Badway, BS; Ashley Wietsma MD, Richard Yu, MD, PhD; Richard S. Lee, MD
Boston Children's Hospital, Boston, MA
8:52 am - 9:00 am 5. Primary Non-Refluxing Megaureter: Analysis of Risk Factors for Spontaneous Resolution and Surgical Intervention
Adriana Dekirmendjian, BHSc1; Mandy Rickard, MN1; Bethany Easterbrook, B.Kin1; Melissa McGrath, BHSc1; Vicki Kam, BHSc1; Natasha Brownrigg, MN1; Jorge E. DeMaria, MD1; Armando J. Lorenzo, MD2; Luis H. Braga, MD1
1McMaster University, Hamilton, ON, Canada; 2Hospital for Sick Children, Toronto, ON, Canada
9:00 am - 9:08 am 6. A Sock Option: Compressive Externally Applied Stockings for Enuresis (CEASE Study)
David J. Chalmers, MD; Gregory J. Mills, BA; Chelsea Paterson, BSN; Brian M. Jumper, MD
Maine Medical Center, Portland, ME
9:08 am - 9:16 am 7. Equilibrated Bladder Pressure at End Filling: A Lower and Less Variable Measure than Maximum Detrusor Pressure
Joseph W. McQuaid, MD; Michael P. Kurtz, MD, MPH; Tanya Logvinenko, PhD; Stuart B. Bauer, MD; Caleb P. Nelson, MD, MPH; Carlos R. Estrada, MD
Boston Children's Hospital, Boston, MA
9:16 am - 9:24 am 8. DSD Management: Balancing Patient Self-Determination with Parental Preferences
David A. Diamond, MD
Boston Children's Hospital, Boston, MA
9:24 am - 9:32 am 9. Transversus Abdominis Plane (TAP) Catheters versus Intraoperative Regional Field Infiltration in Reducing Postoperative Opioid Requirements in Children Undergoing Renal Transplantation: A Retrospective Age-Matched Comparison
Kevin Shee, BS1; Frank J. Penna, MD2; Lael Reinstatler, MD, MPH2; Hissan Butt, BS3; Martin A. Koyle, MD3; Jason Hayes, MD3; Armando J. Lorenzo, MD3
1Geisel School of Medicine at Dartmouth, Lebanon, NH; 2Dartmouth-Hitchcock Medical Center, Lebanon, NH; 3The Hospital for Sick Children, Toronto, ON, Canada
9:32 am - 9:40 am 10. What are the Implications for Obtaining VCUG for All Infants with High Grade Prenatal Hydronephrosis?
Mandy Rickard, MN, NP1; Armando J. Lorenzo, MD2; Adriana Dekirmendjian, BHSc1; Natasha Brownrigg, MN, NP1; Jorge DeMaria, MD1; Luis H. Braga, MD1
1McMaster University, Hamilton, ON, Canada; 2The Hospital for Sick Children, Toronto, ON, Canada
9:40 am - 9:48 am 11. A Single-Institution Series of Perioperative Outcomes Following Robotic Redo Pyeloplasties
Briony Varda, MD; Joseph Badway, BS; Archana Rajender, MD; Ashley Wietsma, MD; Tanya Logvinenko, PhD; Richard S. Lee, MD; Richard N. Yu, MD, PhD
Boston Children's Hospital, Boston, MA
9:50 am - 10:00 am COFFEE BREAK
Westmount Foyer
10:00 am - 11:30 am SCIENTIFIC SESSION II: Oncology: Prostate
Westmount & Outremont (6 minute presentation, 2 minute discussion)
Moderators: Preston C. Sprenkle, MD; Mark A. Preston, MD
10:00 am - 10:08 am *12. Active Surveillance is a Viable Option for Men Under 60 Years of Age with Low-Risk Prostate Cancer
Keyan Salari, MD, PhD1; David Kuppermann, MD1; Mark A. Preston, MD, MPH2; Douglas M. Dahl, MD1; Jason A. Efstathiou, MD, DPhil1; Michael L. Blute, MD1; Danny Vesprini, MD3; Andrew Loblaw, MD3; Anthony L. Zietman, MD1; Laurence Klotz, MD3; Adam S. Feldman, MD, MPH1
1Massachusetts General Hospital, Boston, MA; 2Brigham and Women's Hospital, Boston, MA; 3Sunnybrook Health Sciences Centre, Toronto, ON, Canada
10:08 am - 10:16 am 13. Treatment Trends for Metastatic Prostate Cancer over the Last Decade: Insights from the National Cancer Database
Jared P. Schober, MD; Kristian D. Stensland, MD; Alireza Moinzadeh, MD; David Canes, MD
Lahey Hospital and Medical Center, Burlington, MA
10:16 am - 10:24 am 14. Adverse Effects of Androgen Deprivation Therapy on Cognitive Function and Dementia in Men with Prostate Cancer: A Systematic Review and Meta-Analysis
Alexander P. Cole, MD1; Maxine Sun, PhD1; Nawar Hanna, MD1; Toni K. Chouiri, MD2; Quoc-Dien Trinh, MD1
1Brigham & Women's Hospital, Boston, MA; 2Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology, Boston, MA
10:24 am - 10:32 am 15. MRI-Targeted TRUS-Guided Fusion Biopsy: Are Anterior Targeted Lesions Different then Posterior Lesions Now that we Have Targeting Technology?
Michael Geffin, MD1; James Lin, MD2; Dean Leocadio, MD3; Michael Curran, MD1
1Greater Boston Urology, Dedham, MA; 2Greater Boston Urology, Milton, MA; 3Greater Boston Urology, Falmouth, MA
10:32 am - 10:40 am 16. USPSTF Fallout: Is Disease Burden at Diagnosis of Metastatic Disease Rising?
Jared P. Schober, MD; Kristian D. Stensland, MD; Alireza Moinzadeh, MD; David Canes, MD
Lahey Hospital and Medical Center, Burlington, MA
10:40 am - 10:48 am 17. Perioperative Outcomes of Aspirin Use in Radical Prostatectomy
Matthew D. Ingham, MD; Ross E. Krasnow, MD; Matthew Mossanen, MD; Ye Wang, PhD; Steven L. Chang, MD, MS
Brigham and Women's Hospital, Boston, MA
10:48 am - 10:56 am 18. Clinical and Socioeconomic Disadvantaged Socioeconomic Status is Strongly Associated with Metastatic Prostate Cancer
Jared P. Schober, MD; Kristian D. Stensland, MD; Alireza Moinzadeh, MD; David Canes, MD
Lahey Hospital and Medical Center, Burlington, MA
10:56 am - 11:04 am *19. Secular Trends in Prostate Biopsy Criteria and Outcomes: The Dartmouth Experience
Lael Reinstatler, MD, MPH; Cody M. Rissman, MD; John D. Seigne, MB; Elias S. Hyams, MD
Dartmouth Hitchcock Medical Center, Lebanon, NH
11:04 am - 11:12 am 20. V. A. Multi-Institutional Prospective Study Confirms the 4Kscore Test Predicts Aggressive Prostate Cancer
Stephen M. Zappala, MD1; Sanoj Punnen, MD2; Stacy Loeb, MD3; Edward Uchio, MD4; Stephen Freedland, MD5; Thomas Polascik, MD6; Stephen Savage, MD7; Sharad Mathur, MD8; Michael Risk, MD9; Yan Dong, PhD10; Jonathan Silberstein, MD11
1Andover Urology, Andover, MA; 2Univ of Miami, Miami, FL; 3New York University, New York, NY; 4Univ California, Irvine, Irvine, CA; 5Cedars-Sinai, Los Angeles, CA; 6Duke Cancer Center, Durham, NC; 7Univ of South Carolina, Columbia, SC; 8Kansas City Veterans Center, Kansas City, MO; 9Univ Minnesota, Minneapolis, MN; 10OPKO Diagnostics, Woburn, MA; 11Tulane University, New Orleans, LA
11:12 am - 11:20 am 21. Outcomes of Serial MRI-Fusion Biopsy in Men with Low-Risk Prostate Cancer Managed with Active Surveillance
Jamil S. Syed, MD; Walter Hsiang, BS; Kevin A. Nguyen, MS; Alfredo Suarez-Sarmiento, MD; Michael S. Leapman, MD; Preston C. Sprenkle, MD
Yale Department of Urology, New Haven, CT
11:20 am - 11:28 am 22. Patient Navigation and Its Association with Treatment Selection for Low-Risk Prostate Cancer
Emily C. Serrell, MS1; Moritz H. Hansen, MD1; Gregory J. Mills, BA1; Tracy Robbins, MS2; Andrew Perry, BS2; Melanie Feinberg, BS2;Scot Remick, MD2; Lisa T. Beaule, MD2; Matthew Hayn, MD2; Thomas Kinkead, MD2; Paul Han, MD, MPH1; Jesse D. Sammon, DO1
1Center for Outcomes Research and Evaluation, Portland, ME; 2Maine Medical Center, Portland, ME
10:00 am - 11:30 am CONCURRENT SOCIOECONOMIC SESSION
Mt. Royal - Cote
10:00 am – 10:30 am Coding Pearls
David S. Wang, MD
Boston Medical Center, Boston, MA
10:30 am – 11:00 am Urology Call Coverage – A Growing Problem
Moderator: Anurag K. Das, MD, FACS
Panelists: Gregory S. Adey, MD; Jennifer Yates, MD
11:00 am – 11:30 am Is Private Practice Sustainable Post MACRA?
Moderator: Gyan Pareek, MD
Panelists: Gregory S. Adey, MD; Liam J. Hurley, MD
11:30 am - 12:00 pm Panel I: Transitional Care Urology
Moderator: Hadley Wood, MD
Panelists: Jairam R. Eswara, MD; Erin McNamara, MD, MPH
12:00 pm - 1:30 pm CONCURRENT LUNCH SYMPOSIUM (Non-CME)
Mt. Royal - Cote & Verdun-LaSalle
1:30 pm - 2:00 pm STATE OF THE ART LECTURE I: The Lost Myelomeningocele Patient: Consideration for Evaluation, Surveillance and Treatment
Hadley Wood, MD
Cleveland Clinic Foundation, Cleveland, OH
2:00 pm - 3:30 pm SCIENTIFIC SESSION III: Stones
Westmount & Outremont (6 minute presentation, 2 minute discussion)
Moderators: Kevan Sternberg, MD; Jessica A. Mandeville, MD
2:00 pm - 2:08 pm 23. Early Discharge Following Decompression for Sepsis and an Obstructing Stone? A Multi-Institutional Study to Identify Predictors of Antibiotics Sensitivity
Timothy Tran, MD1; Madeline Cancian, MD1; Egor Parkhomenko, MD2; Mantu Gupta, MD2; Gyan Pareek, MD1
1Alpert Medical School at Brown University, Providence, RI; 2Icahn School of Medicine at Mount Sinai, New York, NY
2:08 pm - 2:16 pm 24. A Randomized Control Trial of Preoperative Prophylactic Antibiotics Prior to Percutaneous Nephrolithotomy in the Low Risk Population: A Report from the EDGE Consortium
Annah J. Vollstedt, MD1; Seth K. Bechis, MD2; Joel E. Abbott, DO2; Ben H. Chew, MD3; Nicole L. Miller, MD4; Amy E. Krambeck, MD5; Mitchell R. Humphreys, MD6; Manoj Monga, MD7; Roger L. Sur, MD2; Vernon M. Pais, Jr., MD1
1Dartmouth Hitchcock Medical Center, Lebanon, NH; 2University of California, San Diego, San Diego, CA; 3The Ohio State University Wexner Medical Center, Columbus, OH; 4Vanderbilt University Medical Center, Nashville, TN; 5Indiana University, Indianapolis, IN; 6Mayo Clinic, Phoenix, AZ, 7Cleveland Clinic, Cleveland, OH
2:16 pm - 2:24 pm 25. Radiation Exposure during Percutaneous Nephrolithotomy: A Comparative Analysis of Single Specialty versus Multi-Specialty Procedures
Sanchita Bose, MD1; Priyanka Bearelly, MD1; Jerilyn M. Latini, MD2; Ruslan Korets, MD2
1Boston Medical Center, Boston, MA; 2Veterans Affairs Boston Healthcare System, Harvard Medical School, Boston, MA
2:24 pm - 2:32 pm 26. A Decision Analysis of Observation vs. Immediate Re-Intervention for Asymptomatic Residual Fragments & lt 4mm Following Ureteroscopic Lithotripsy
Michal Ursiny, MD1; Alan Yaghoubian, MD1; Mitchell Humphreys, MD2; Hilary Brotherhood, MD3; Benjamin Chew, MD3; Manoj Monga, MD4; Amy Krambeck, MD5; Cameron Charchenko, MD6; An Qi Wang, BS7; Roger Sur, MD7; Nicole Miller, MD8; Tracy Marien, MD8; Yui-Hui Chang, BS6; Bodo Knudsen, MD9; Courtney Yong, MD10; Brian Matlaga, MD11; Ojas Shah, MD12; Vernon Pais, MD13; Brian Eisner, MD1
1Massachusetts General Hospital, Boston, MA; 2Mayo Clinic Arizona, Phoenix, AZ; 3University of British Columbia, Vancouver, BC, Canada; 4Cleveland Clinic, Cleveland, OH; 5University of Indiana, Indianapolis, IN; 6Mayo Clinic, Rochester, MN; 7UCSD, San Diego, CA; 8Vanderbilt University, Nashville, TN; 9Ohio State University, Columbus, OH; 10University of Iowa, Iowa City, IA; 11Johns Hopkins University, Baltimore, MD; 12Columbia University, New York, NY; 13Dartmouth-Hitchcock Medical Center, Hanover, NH
2:32 pm - 2:40 pm 27. The Effect of Medication use on Stone-Related Quality of Life
Eric P. Raffin, MD1, Kristina L. Penniston, RD2, Rebecca Smith, MS1, Lawrence Dagrosa, MD1; Jodi A. Antonelli, MD3; Davis P. Viprakasit, MD4; Timothy D. Averch, MD5; Vincent G. Bird, MD6; Ben H. Chew, MD7; Sri Sivalingam, MD8; Roger L. Sur, MD9; Stephen Y. Nakada, MD2; Vernon M. Pais, MD1
1Dartmouth Hitchcock Medical Center, Lebanon, NH; 2University of Wisconsin School of Medicine and Public Health, Madison, WI; 3University of Texas Southwestern Medical Center, Dallas, TX; 4University of North Carolina School of Medicine, Chapel Hill, NC; 5University of Pittsburgh Medical Center, Pittsburgh, PA; 6University of Florida College of Medicine, Gainesville, FL; 7University of British Columbia Department of Urologic Sciences, Vancouver, BC, Canada; 8Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, OH; 9University of California San Diego School of Medicine, San Diego, CA
2:40 pm - 2:48 pm 28. Percutaneous Renal Access by Urologist vs Radiologist: Trends and Perioperative Outcomes in PCNL
Jacqueline M. Speed, MD1; Ye Wang, PhD1; Jeffrey J. Leow, MBBS, MPH1;Tyler R. McClintock, MD, MS1; Naeem Bhojani, MD2; Quoc-Dien Trinh, MD1; Steven L. Chang, MD, MS1; Ruslan Korets, MD3
1Brigham and Women's Hospital, Boston, MA; 2Universite de Montreal, Montreal, QC, Canada; 3Veterans Affairs Boston Healthcare System, Harvard Medical School, Boston, MA
2:48 pm - 2:56 pm 29. Analysis of Stent Omission after Uncomplicated Ureteroscopic Lithotripsy Shows Significant Cost Savings and Decreased Patient Morbidity
Paul E. Bower, MD; Danielle Velez, MD; Simone Thavaseelan, MD; Gyan Pareek, MD
Brown University, Providence, RI
2:56 pm - 3:04 pm *30. Association of Pregnancy with Stone Formation among US Women: A National Health and Nutrition Examination Survey Analysis 2007-2012
Lael Reinstatler, MD, MPH; Sari Khaleel, MD; Vernon M. Pais, Jr., MD, MPH
Dartmouth Hitchcock Medical Center, Lebanon, NH
3:04 pm - 3:12 pm 31. Initial Outcomes of Supine PCNL in the United States: Another Arrow for the Urologist's Quiver
Priyanka Bearelly, MD1; Sanchita Bose, MD1; Jacqueline M. Speed, MD2; Jerilyn M. Latini, MD3; Ruslan Korets, MD3
1Boston Medical Center, Boston, MA; 2Brigham and Women's Hospital, Boston, MA; 3Veterans Affairs Boston Healthcare System, Harvard Medical School, Boston, MA
3:12 pm - 3:20 pm 32. Bacteria on Urine Microscopy is not associated with Systemic Infection in Patients with Obstructing Urolithiasis
Felix Cheung, MD; Charles A. Loeb, BA; Michael P. Croglio, BS; Wayne C. Waltzer, MD; Steven J. Weissbart, MD
Stony Brook University, Stony Brook, NY
3:20 pm - 3:28 pm 33. A Retrospective Pilot Study Comparing the Efficacy of Opioids and Diclofenac for Post-Ureteroscopy Pain Control
David W. Sobel, MD; Theodore Cisu, BS; Kevan M. Sternberg, MD
University of Vermont, Burlington, VT
2:00 pm - 3:30 pm CONCURRENT POSTER SESSION I: Translational Research/Oncology
Verdun - LaSalle (3 minute presentation, 2 minute discussion)
Moderators: Florian Schroeck, MD; Mark H. Katz, MD
2:00 pm - 2:15 pm Poster Viewing Time
2:15 pm - 2:20 pm P1. The Learning Curve for Multi-parametric MRI/US Fusion Guided Prostate Biopsy: A Single Center Experience
Cynthia P. Leung, MD1; Jamil S. Syed, BS1; Shu Pan, MD1; Thomas B. Neville, PhD2; Preston C. Sprenkle, MD1
1Yale University, New Haven, CT; 2Soar BioDynamics, Inc., New Haven, CT
2:20 pm - 2:25 pm P2. Metformin Inhibits Benign Prostatic Epithelial Cells through Suppression of Insulin-Like Growth Factor 1 Receptor
Zongwei Wang, PhD1; Xingyuan Xiao, MD1; Rongbin Ge, PhD, MD2; Jijun Li, MD1; Cameron Johnson, BS1; Cyrus Rassoulian, N/A1; Aria Olumi, MD1
1Massachusetts General Hospital, Boston, MA; 2University of Massachusetts Medical Center, Boston, MA
2:25 pm - 2:30 pm P3. Urothelial Genes Modulating Micturition Behavior Induced by a Repetitive Lipopolysaccharide (LPS) Exposure in an Ovariectomized (OVX) Mouse Model
Marian Acevedo, MD1; Judy Yeh, MD1; Lery Alvarez-Lugo, MS1; Ming Lu, MD1; Nitin Sukumar, MS1; Warren Hill, PhD2; Toby C. Chai, MD1
1Yale University, New Haven, CT; 2Harvard Medical School, Boston, MA
2:30 pm - 2:35 pm P4. A Novel, Integrated Gene Expression and Drug Sensitivity Approach Reveals Unique Sensitivity of Squamous Cell Carcinoma-Like Bladder Cancers to PI3K-Beta Inhibitor AZD6482
Kevin Shee, BS1; Kevin Koo, MD, MPH, MPhil2; Lael Reinstatler, MD, MPH2; John Seigne, MD2; Todd W. Miller, PhD1
1Geisel School of Medicine at Dartmouth, Lebanon, NH; 2Dartmouth-Hitchcock Medical Center, Lebanon, NH
2:35 pm - 2:40 pm P5. The Role of Integrins and Exosomes in Sunitinib Resistance in ccRCC Cell Lines
Jared P. Schober, MD; Marc Calabrese, MD; Daniel Kaufman, MD; Kevin Yang, MD; Kristian D. Stensland, MD; Juliana Kostas, N/A; Travis Sullivan, MS; Kimberly Rieger-Christ, PhD
Lahey Hospital and Medical Center, Burlington, MA
2:40 pm - 2:45 pm P6. Genomic Heterogeneity and the Small Renal Mass
Daiki Ueno, MD1, Marta Boeke, PhD1, Jamil S. Syed, MD1, Kevin A. Nguyen, MS1, Patrick Macgillivray, MD2, Adebowale Adeniran, MD3, Peter Humphrey, MD PhD3, Yuval Kluger, PhD3, Zhonzhi Liu, PhD3, Harriet Kluger, MD4, Brian Shuch, MD1
1Yale Department of Urology, New Haven, CT; 2Yale Department of Molecular Biophysics and Biochemistry, New Haven, CT; 3Yale Department of Pathology, New Haven, CT; 4Yale Department of Medicine, New Haven, CT
2:45 pm - 2:50 pm P7. Protein Expression in Urethral Lichen Sclerosus: Potential for Biochemical Identification and Early Cancer Warning
Kristian D. Stensland, MD; Jennifer A. Bennett, MD; Brendan M. Browne, MD; Ariel K. Fredrick, MD; Jared P. Schober, MD; Travis B. Sullivan, MS; Kim M. Rieger-Christ, PhD; Alex J. Vanni, MD
Lahey Hospital and Medical Center, Burlington, MA
2:50 pm - 2:55 pm P8. Whole-genome Analysis of Papillary Kidney Cancer Finds Significant Non-Coding Alterations
Shantao Liu, PhD1; Brian Shuch, MD2; Mark Gerstein, PhD1
1Yale Department of Molecular Biophysics and Biochemistry, New Haven, CT; 2Yale Department of Urology, New Haven, CT
2:55 pm - 3:00 pm P9. Urine Expression of TIMP-1, serpinB1 and seminogelin 2 may Differentiate Those Men with Low Risk or No Evidence of Prostate Cancer from Men with High Risk or Metastatic Disease
Adam S. Feldman, MD, MPH; Sarah Prophet, BA; Mary Fergus, BA; Bruce Zetter, PhD
Massachusetts General Hospital, Boston, MA
3:00 pm - 3:05 pm P10. Protective Effects of Melittin on Renal Fibrosis in an Animal Model of Unilateral Ureteral Obstruction
Kwan-Kyu Park, MD, PhD; Hyun-Jin An, PhD; Woon-Hae Kim, MSc; Mi-Gyeong Gwon, BSc; Hyemin Gu, BSc; Minji Jeon, BSc; Hyun Chung, MD,PhD
College of medicine, Catholic university of Daegu, Daegu, Korea, Republic of
3:05 pm - 3:10 pm P11. The Use of Prostate-Specific Antigen Velocity as a Screening Tool for Pre-Biopsy Detection of Prostate Cancer and Differentiation of High-Grade Disease in African American Men
Zachary S. Feuer, BS1; Daniel A. Segal, BS1; Clara Oromendia, MS2; Frank A. Myers, Jr., MD3; Samuel Gold, BS1; Jeffrey P. Weiss, MD1; Brian K. McNeil, MD1; Llewellyn M. Hyacinthe, MD1; Andrew G. Winer, MD3
1SUNY Downstate College of Medicine, Brooklyn, NY; 2Weill Cornell Medicine, Division of Biostatistics and Epidemiology, New York, NY; 3Kings County Hospital Center, Department of Urology, Brooklyn, NY
3:10 pm - 3:15 pm P12. Leveraging Big Data to Study Bladder Cancer Care
Florian R. Schroeck, MD, MS1,2; Brenda Sirovich, MD, MS1; John D. Seigne, MBBS2; Douglas J. Robertson, MD, MPH1; Philip P. Goodney, MD, MS1
1White River Junction VA Medical Center, White River Junction, VT; 2Section of Urology and Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH
3:15 pm - 3:20 pm P13. The Association of Age with Perioperative Morbidity and Mortality among Patients Undergoing Radical Cystectomy or Partial Nephrectom
Jorge Pereira, MD; Joseph Renzulli, MD; Gyan Pareek, MD; Dragan Golijanin, MD; Boris Gershman, MD
Warren Alpert School of Medicine at Brown University, Division of Urology, Providence, RI
3:20 pm - 3:25 pm P14. Androgenic to Estrogenic Switch in Human Adult Prostate Gland as a result of Epigenetic Silencing of Steroid 5-alpha Reductase 2
Zongwei Wang, PhD1; Libing Hu, MD1; Rongbin Ge, PhD, MD2; Keyan Salari, MD1; Shulin Wu, MD1; Seth Bechis, MD1; Cyrus Rassoulian, N/A1; Jonathan Pham, MD candidate1; Chin-Lee Wu, PhD, MD3; Shahin Tabetabaei, MD1; Douglas Strand, PhD4; Aria Olumi, MD1
1Massachusetts General Hospital, Boston, MA; 2University of Massachusetts Medical Center, Worcester, MA; 3Massachusetts General Hospital, Belmont, MA; 4UT Southwestern Medical Center, Dallas, TX
3:25 pm - 3:30 pm *P15. Survival Outcomes for Patients with Localized Upper Tract Urothelial Carcinoma Managed with Watchful Waiting
Jamil S. Syed, MD1; Kevin A. Nguyen, MS1; Katelyn Johnson, BS1; Ansh Bhagat, BS1; Jay Raman, MD2; Brian Shuch, MD1
1Yale Department of Urology, New Haven, CT; 2Pennsylvania State University, Hershey, PA
3:30 pm - 3:45 pm COFFEE BREAK
Westmount Foyer
3:45 pm - 4:15 pm PANEL II: Appropriate Use of ESWL/URS/PCNL
Westmount & Outremont
Moderator: Vernon M. Pais, Jr., MD
Panelists: Gyan Pareek MD; Ruslan Korets, MD; Peter L. Steinberg, MD
4:15 pm - 4:45 pm AUA GUIDELINES UPDATE
Westmount & Outremont
John D. Seigne, MD
Dartmouth-Hitchcock Medical Center, Lebanon, NH
4:45 pm - 5:15 pm PANEL III: Management of Advanced Prostate Cancer
Westmount & Outremont
Moderator: Mitchell Sokoloff, MD
Panelists: Mathew F. Wszolek, MD; Matthew Hayn, MD; Joseph R. Wagner, MD
5:15 pm- 5:45 pm AUA RESEARCH OVERVIEW
Toby C. Chai, MD
Yale University, New Haven, CT
5:45 pm - 7:00 pm WELCOME RECEPTION IN EXHIBIT HALL
Fontaine
 
FRIDAY, SEPTEMBER 8, 2017
6:30 am - 5:00 pm REGISTRATION DESK
Inscription
6:30 am - 8:00 am BREAKFAST SYMPOSIUM (Non-CME)
Mt. Royal - Cote
7:00 am - 5:00 pm SPEAKER READY ROOM
St. Lambert
7:30 am - 8:30 am CONTINENTAL BREAKFAST, VISIT EXHIBITS
Fontaine
7:30 am - 12:30 pm
2:00 pm - 6:30 pm
EXHIBIT HALL
Fontaine
8:00 am - 12:00 pm HOSPITALITY SUITE
Salon Bonaventure
8:00 am - 9:30 am SCIENTIFIC SESSION IV: Female/Infertility/Incontinence
Westmount & Outremont (6 minute presentation, 2 minute discussion)
Moderators: Veronica Triaca, MD; Lara Maclachlan, MD
8:00 am - 8:08 am 34. Regional Variation in Diagnostic Testing for Overactive Bladder in the Female Medicare Population
Annah J. Vollstedt, MD; Rachel Moses, MD, MPH; E. Ann Gormley, MD
Dartmouth Hitchcock Medical Center, Lebanon, NH
8:08 am - 8:16 am 35. Predictors of Macroplastique Success in the Treatment of Incontinent Women
Max Schmidt-Bowman, BS1; Annah Vollstedt, MD2; Zhonge Li, MS3; Veronica Triaca, MD4
1Geisel School of Medicine, Hanover, NH; 2Dartmouth Hitchcock Medical Center, Lebanon, NH; 3Biostatistics Shared Resource, Norris Cotton Cancer Center, Dartmouth College, Lebanon, NH; 4Concord Hospital for Urologic Care, Concord, NH
8:16 am - 8:24 am 36. Factors Associated With Durability of Intravesical Botulinum Toxin a Injection
Jay Vance, MS1; Kristian Stensland, MD2; Bennett Sluis, BS1; Arthur Mourtzinos, MD MBA2; Lara MacLachlan, MD2
1Tufts University School of Medicine, Boston, MA; 2Lahey Hospital & Medical Center, Burlington, MA
8:24 am - 8:32 am 37. A Retrospective Analysis of Risk Factors for IPP Reservoir Entry into the Peritoneum after Posterior to Transversalis Fascia Placement
Martin S. Gross, MD1; Bruce B. Garber, MD2; Doron S. Stember, MD3; Paul E. Perito, MD4
1Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Lebanon, NH; 2Hahnemann University Hospital, Philadelphia, PA; 3Mount Sinai Hospital, New York City, NY; 4Perito Urology, Coral Gables, FL
8:32 am - 8:40 am 38. Fascia Lata Sling a Viable Alternative for Stress Incontinence
Mary Grey Maher, MD; Sophia Delphe, MD
Yale University School of Medicine, New Haven, CT
8:40 am - 8:48 am 39. Transgender Sperm Cryopreservation: Trends and Findings in the Past Decade
Kai Li, MD1; Dayron Rodriguez, MD1; Joseph S. Gabrielsen, MD, PhD1; Amy Blanchard, BS2; Grace Centola, PhD2; Cigdem Tanrikut, MD1
1Massachusetts General Hospital, Boston, MA; 2New England Cryogenic Center, Boston, MA
8:48 am - 8:56 am 40. The Impact of the FDA Testosterone Supplementation Therapy Safety Advisory on Prescribing Patterns
Valary T. Raup, MD1; Tyler McClintock, MD1; Alexandra Berger, MD1; Allen Seftel, MD2; Martin Kathrins, MD1
1Brigham and Women's Hospital, Harvard Medical School, Boston, MA; 2Cooper University Hospital, Camden, NJ
8:56 am - 9:04 am 41. Predictors of Nerve Stimulation Success in Patients with Overactive Bladder
Bennett Sluis, BA1; Kristian Stensland, MD2; Jay Vance, MS1; Jared Schober, MD2; Lara MacLachlan, MD2; Arthur Mourtzinos, MD, MBA2
1Tufts University School of Medicine/Lahey Hospital and Medical Center, Boston, MA; 2Lahey Hospital and Medical Center, Burlington, MA
9:04 am - 9:12 am 42. The Efficacy of Durasphere as a New Agent for the Treatment of Hypermobile Glans
Martin S. Gross, MD1; Jared Wallen, MD2; SriGita Madiraju, MD3; Kevin Tayon, MD3; Rafael E. Carrion, MD2; Paul E. Perito, MD4
1Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Lebanon, NH; 2USF Morsani College of Medicine, Tampa, FL; 3FAU Charles E. Schmidt College of Medicine, Boca Raton, FL; 4Perito Urology, Coral Gables, FL
9:12 am - 9:20 am 43. Sexual Function in Men After Radical Cystoprostatectomy Differs in Men with Ileal Conduit Compared to Orthotropic Neobladder Urinary Diversion
Charlotte Q. Wu, MD; Stanton Honig, MD; Thomas V. Martin, MD; David G. Hesse, MD
Yale New Haven Hospital, New Haven, CT
9:20 am - 9:28 am 44. Factors Affecting Dropout Rate in Patients Undergoing Percutaneous Tibial Nerve Stimulation
William T. Berg, MD; Wai Lee, MD; Charles A. Loeb, BA; Chris Du, BA; Andrew Chen, BS; Jason Kim, MD
Stony Brook University, Stony Brook, NY
9:30 am - 10:00 am Panel IV: Management of Peyronie's
Westmount & Outremont
Moderator: Kathleen Hwang, MD
Panelists: Martin Gross, MD; Katie Rotker, MD
10:00 am - 10:30 am COFFEE BREAK, VISIT EXHIBITS
Fontaine
10:30 am - 11:00 am PANEL V: Management of Refractory OAB
Westmount & Outremont
Moderator: Elizabeth A. Gormley, MD
Panelists: Richard T. Kershen, MD; Anurag K. Das, MD; Arthur P. Mourtzinos, MD
11:00 am - 12:30 pm SCIENTIFIC SESSION V: BPH/Gen/Health Policy/Best Practice
Westmount & Outremont (6 minute presentation, 2 minute discussion)
Moderators: Shahin Tabatabei, MD; Quoc-Dien Trinh, MD
11:00 am - 11:08 am 45. How Much is Just Right? An Evaluation of Post-Operative Opioid Prescribing for Urologic Procedures at a Single Institution
Kathleen M. Olson, BS; Theodore Cisu, BS; Peter Holoch, MD; Mayo H. Fujii, MD; Thomas P. Ahern, PhD, MPH; Charles D. Maclean, MD
University of Vermont, Burlington, VT
11:08 am - 11:14 am 46. The Difficult Catheter Placement: Can we Protect Hospitalized Patients from Iatrogenic Catheter Injury and Reduce Unnecessary Urology Consults?
Charlotte Q. Wu, MD; Nnenaya Q. Agochukwu, MD; Roland Assi, MD; David G. Hesse, MD
Yale New Haven Hospital, New Haven, CT
11:14 am - 11:22 am 47. Using the Lean Model Decreases the Overuse of Perioperative Antibiotics During Endourologic Surgery
Thomas Calvert, MD, MPH; Jennifer Yates, MD
UMass Memorial Medical Center, Worcester, MA
11:22 am - 11:30 am 48. Prostate Cancer Screening in Early Medicaid Expansion States
Emily C. Serrell, MS1; Jesse D. Sammon, DO1; Patrick Karabon, MS2; Gregory J. Mills, BA1; Mani Menon, MD2; Firas Abdollah, MD2; Quoc Dien-Trinh, MD3
1Center for Outcomes Research and Evaluation, Portland, ME; 2Henry Ford Health System, Detroit, MI; 3Brigham and Women's Hospital, Boston, MA
11:30 am - 11:38 am 49. Nation-Wide Utilization of Chemoprophylaxis for the Prevention of VTE in Radical Cystectomy: How Well Do Urologists Follow the Guidelines?
Stephen Reese, MD; Matthew Mossanen, MD; Steven Chang, MD
Brigham and Women's Hospital, Boston, MA
11:38 am - 11:46 am 50. Simulation in Urology Residency: Teaching Technique, Clinical Reasoning and Medical Knowledge in Urinary Incontinence
Simone Thavaseelan, MD; Rashmi Licht, MD; Janice Santos, MD
Brown University, Providence, RI
11:46 am - 11:54 am 51. Breaking Through: Elizabeth Ann Gormley and a History of Firsts for Women in Urology
Kevin Koo, MD, MPH, MPhil1; Deborah J. Lightner, MD2
1Dartmouth-Hitchcock Medical Center, Lebanon, NH; 2Mayo Clinic, Rochester, MN
11:54 am - 12:02 pm 52. A study of Resident Sleep Patterns in Relation to Volume and Category of Overnight Pages in a Home Call System
Adam Ludvigson, MD; Gregory Mills, BA; Stephen T. Ryan, MD; Graham VerLee, MD; Moritz Hansen, MD
Maine Medical Center, Portland, ME
12:02 pm - 12:10 pm 53. Multi-Institutional Pilot Evaluation of an Online Feedback Platform for Surgical Skill Acquisition
Marc D. Manganiello, MD1; George E. Haleblian, MD2; David Canes, MD3; Peter Chang, MD1; Andrew A. Wagner, MD1; Ruslan Korets, MD4
1Beth Israel Deaconess Medical Center, Boston, MA; 2Brigham and Women's Hospital, Boston, MA; 3Lahey Hospital and Medical Center, Burlington, MA, 4Veterans Affairs Boston Healthcare System, Boston, MA
12:10 pm - 12:18 pm 54. 180 W XPS GreenLight Laser Vaporization of the Prostate in High Surgical Risk Patients: 48-month Safety and Efficacy Results for Patients with ASA Score of 3 or Greater
Naren Nimmagadda, MD; Bo Wu, MD; Mahdi Zangi, MD, MPH; Shahin Tabatabaei, MD
Massachusetts General Hospital, Boston, MA
12:18 pm - 12:26 pm 55. PSA screening at the intersection of Politics and Policy
Jesse D. Sammon, DO1; Emily C. Serell, MS2; Malte Vetterlein, MD2; Patrick Karabon, MS3; Gregory J. Mills, BA1; Moritz H. Hansen, MD1; Mani Menon, MD3; Quoc Dien-Trinh, MD2; Firas Abdollah, MD3
1Center for Outcomes Research and Evaluation, Portland, ME; 2Brigham and Women's Hospital, Boston, MA; 3Henry Ford Health System, Detroit, MI
11:00 am - 12:30 pm CONCURRENT POSTER SESSION II: Other
Verdun - Lasalle (3 minute presentation, 2 minute discussion)
Moderators: Richard T. Grunert, MD; Jesse D. Sammon, MD
11:00 am - 11:15 am Poster Viewing Time
11:15 am - 11:20 am P16. Patient Risk Reclassification Based on Combined Clinical Cell Cycle Risk (CCR) Score
Mitchell H. Sokoloff, MD, FACS1; Steven Stone, PhD2; Julia Reid, MStat2; E. David Crawford, MD3; Michael K. Brawer, MD2
1University of Massachusetts Medical School and UMass Memorial Health Care, Worcester, MA; 2Myriad Genetics, Inc., Salt Lake City, UT; 3University of Colorado, Aurora, CO, USA
11:20 am - 11:25 am P17. New Data Regarding HIV Status as a Predictor of Postoperative IPP Infection
Martin S. Gross, MD1; Jared Wallen, MD2; SriGita Madiraju, MD3; Kevin Tayon, MD3; Natan Davoudzadeh, MD4; Harris M. Nagler, MD4; Paul E. Perito, MD5; Ricardo M. Munarriz, MD6; Doron S. Stember, MD4
1Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Lebanon, NH; 2USF Morsani College of Medicine, Tampa, FL; 3FAU Charles E. Schmidt College of Medicine, Boca Raton, FL; 4Mount Sinai Hospital, New York City, NY; 5Perito Urology, Coral Gables, FL; 6Boston Medical Center, Boston, MA
11:25 am - 11:30 am P18. Gender-Based Differences in the Durability of Intravesical Botulinum Toxin a Injection
Jay Vance, MS1; Kristian Stensland, MD2; Bennett Sluis, BS1; Arthur Mourtzinos, MD MBA2; Lara MacLachlan, MD2
1Tufts University School of Medicine, Boston, MA; 2Lahey Hospital & Medical Center, Burlington, MA
11:30 am - 11:35 am P19. Separating the Wheat from the Chaff: an Evaluation of Readability, Quality, and Accuracy of Online Health Information for Treatment of Peyronie's Disease
Theodore Cisu, BS; Nicholas J. Bompastore, BA; Peter Holoch, MD
University of Vermont College of Medicine, Burlington, VT
11:35 am - 11:40 am P20. Low Incidence of Clean Intermittent Catheterization with OnabotulinumtoxinA in Diverse Age Groups of Overactive Bladder Patients and Substantial Improvements in Urinary Symptoms and Quality of Life
Victor Nitti, MD1; Sidney Radomski, MD2; Eric Rovner, MD3; Marcus Drake, MD4; Karel Everaert, MD5; Christopher Chapple, MD6; David Ginsberg, MD7; Tamer Aboushwareb, MD8; Cheng-Tao Chang, PhD9; Roger Dmochowski, MD10; Benjamin Brucker, MD1
1New York University Langone Medical Center, New York, NY; 2University of Toronto, Toronto, ON, Canada; 3Medical University of South Carolina, Charleston, SC; 4Bristol Urological Institute, Bristol, United Kingdom; 5Ghent University Hospital, Ghent, Belgium; 6The Royal Hallamshire Hospital, Sheffield Teaching Hospitals, NHS Foundation Trust, Sheffield, United Kingdom; 7USC Institute of Urology, Los Angeles, CA; 8Allergan plc, Irvine, CA; 9Allergan plc, Bridgewater, NJ; 10Vanderbilt University Medical Center, Nashville, TN
11:40 am - 11:45 am P21. New Data Regarding Penile Length Preservation after IPP Implantation
Martin S. Gross, MD1; Jared Wallen, MD2; Hajar Ayoub, MD3; O. Lenaine Westney, MD3; Paul E. Perito, MD4
1Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Lebanon, NH; 2USF Morsani College of Medicine, Tampa, FL; 3University of Texas Health Sciences Center at Houston, Houston, TX; 4Perito Urology, Coral Gables, FL
11:45 am - 11:50 am P22. Gender Based Effect Modification of Nerve Stimulator Success in Patients with Overactive Bladder
Bennett Sluis, MA1; Kristian Stensland, MD2; Jay Vance, MS1; Lara MacLachlan, MD2; Arthur Mourtzinos, MD MBA2
1Tufts University School of Medicine, Boston, MA; 2Lahey Hospital and Medical Center, Burlington, MA
11:50 am - 11:55 am P23. The Effect of Marital Status on Post-Operative Outcomes after PCNL
Jacqueline M. Speed, MD1; Alexander P. Cole, MD1; Jerilyn M. Latini, MD2; Tyler R. McClintock, MD, MS1; Ye Wang, PhD1; Steven L. Chang, MD, MS1; Ruslan Korets, MD2
1Brigham and Women's Hospital, Boston, MA; 2Veterans Affairs Boston Healthcare System, Harvard Medical School, Boston, MA
11:55 am - 12:00 pm P24. Trends in Imaging Use for the Evaluation and Follow-Up of Kidney Stone Disease: A Single Center Experience
Kevan Sternberg, MD; Benjamin Littenberg, MD
University of Vermont, Burlington, VT
12:00 pm - 12:05 pm *P25. Impact of Prior Ureteral Stent on Future Treatment Decisions: EDGE Multi-Institutional Survey
Annah J. Vollstedt, MD1, Rajiv Raghavan, BS1; Manoj Monga, MD2; Anna Zampini, MD, MBA, MS2; Ojahs Shah, MD3; Rafael Yanes, MD3; Stephanie Thompson, MS3; Amy Krambeck, MD4; Vernon Pais, Jr., MD1
1Dartmouth Hitchcock Medical Center, Lebanon, NH; 2Cleveland Clinic, Cleveland, OH; 3Columbia University, New York, NY; 4Indiana University, Indianapolis, IN
12:05 pm - 12:10 pm P26. EPIC 26 Identifies Men Likely to Benefit from Surgical Interventions for Male Stress Incontinence after Radical Prostatectomy
Syed Alam, BA, MS1; Ilene Staff, PhD2; Tara McLaughlin, PhD2; Alison Champagne, BS2; Joseph Tortora, MS2; Richard Kershen, MD2; Joseph Wagner, MD2
1University of Connecticut, Farmington, CT; 2Hartford Hospital, Department of Surgery, Hartford, CT
12:10 pm - 12:15 pm P27. Using Electronic Health Records Data in Practice Audit: Ureteroscopy- Stent or No Stent?
Emmanuel Abara, FRCSC, FACS, FICS
Richmond Hill Urology Practice & Prostate Institute, Richmond Hill, ON, Canada
12:15 pm - 12:20 pm P28. Renal Malignancy and Peritumor Fat: Is It Necessary to Send Perinephric Fat for Pathology During Partial Nephrectomy?
Didi Theva, MD; Liz Wang, BA; Gabriella Avellino, MD; Mark Katz, MD; Richard Babayan, MD; David Wang, MD
Boston Medical Center, Boston, MA
12:20 pm - 12:25 pm P29. Comparative Effectiveness of Neoadjuvant Chemotherapy vs. Surgery Alone for Upper Tract Urothelial Carcinoma
Kristian D. Stensland, MD; Brendan M. Browne, MD; Marc D. Calabrese, MD; Matthew J. Moynihan, MD, MPH; Jared P. Schober, MD; David Canes, MD
Lahey Hospital and Medical Center, Burlington, MA
12:25 pm - 12:30 pm P30. Examining the Association between Biopsy and Clinical Staging in Upper Tract Urothelial Cancer
Brendan M. Browne, MD; Kristian D. Stensland, MD; David Canes, MD
Lahey Hospital and Medical Center, Burlington, MA
12:30 pm - 2:00 pm CONCURRENT LUNCH SYMPOSIUM (Non-CME)
Mt. Royal - Cote
2:00 pm - 2:15 pm AUA GUIDELINES UPDATE
Westmount & Outremont

Surgical Treatment of SUI
E. Ann Gormley, MD
Dartmouth-Hitchcock Medical Center, Lebanon, NH
2:15 pm – 2:30 pm AUA GUIDELINES UPDATE
Westmount & Outremont

Treatment of Non–Metastatic Muscle Invasive Bladder Cancer
John D. Seigne, MD
Dartmouth-Hitchcock Medical Center, Lebanon, NH
2:30 pm - 3:00 pm STATE OF THE ART LECTURE II: Prostate Cancer
Westmount & Outremont
Adam S. Kibel, MD
Brigham & Women's Hospital, Boston, MA
3:00 pm - 4:05 pm SOCIOECONOMIC SESSION
Westmount & Outremont
3:00 pm - 3:45 pm Patient Centered Surgical Home
Mitchell H. Sokoloff, MD
UMass Memorial Medical Center, Worcester, MA
3:45 pm - 4:05 pm Aging Workforce
Kevin R. Loughlin, MD, MBA
Harvard Medical School, Boston, MA
4:05 pm - 4:30 pm COFFEE BREAK, VISIT EXHIBITS
Fontaine
4:30 pm - 5:30 pm SOCIOECONOMIC SESSION
Westmount & Outremont
4:30 pm – 4:50 pm HCP Implications to Urology Practice
Quoc-Dien Trinh, MD
4:50 pm – 5:10 pm MACRA Update
Brian H. Irwin, MD
University of Vermont, Burlington, VT
5:10 pm – 5:30 pm MACRA Panel Discussion
Moderator: Brian H. Irwin, MD
Panelists: Michael J. Curran, MD, Lisa Miller-Jones, MD; Arthur E. Tarantino, MD
5:30 pm - 6:30 pm ATTENDEE RECEPTION IN EXHIBIT HALL
Fontaine
 
SATURDAY, SEPTEMBER 9, 2017
7:00 am - 3:30 pm REGISTRATION DESK
Inscription
7:00 am - 3:30 pm SPEAKER READY ROOM
St. Lambert
7:15 am - 8:00 am CONTINENTAL BREAKFAST, VISIT EXHIBITS
Fontaine
7:15 am - 11:00 am EXHIBIT HALL
Fontaine
8:00 am - 12:00 pm HOSPITALITY SUITE
Salon Bonaventure
7:30 am - 8:00 am ANNUAL BUSINESS MEETING, Members Only
Westmount & Outremont
8:00 am - 9:30 am SCIENTIFIC SESSION VI: Cancer: Non-Prostate Cancer
Westmount & Outremont (6 minute presentation, 2 minute discussion)
Moderators: Adam S. Feldman, MD; Jennifer Yates, MD
8:00 am - 8:08 am 56. Impact of Adequate Pelvic Lymph Node Dissection on Overall Survival after Radical Cystectomy: A Stratified Analysis by Stage and Receipt of Neoadjuvant Chemotherapy
Alexander P. Cole, MD1; Nicolas von Landenburg, MD2; Philipp Gild, MD3; Jacqueline Speed, MD1; Thomas Seisen, MD4; Quoc-Dien Trinh, MD1
1Brigham & Women's Hospital- Division of Urological Surgery, Boston, MA; 2Ruhr-University Bochum, Marien Hospital Herne- Department of Urology, Herne, Germany; 3University Medical Center Hamburg-Eppendorf- Department of Urology, Hamburg, Germany; 4Hopital Pitié-Salpétrière- Service d'Urologie, Paris, France
8:08 am - 8:16 am 57. Harnessing Full Text Pathology Data from the Electronic Health Record to Advance Bladder Cancer Care - Development of a Natural Language Processing System to Generate Longitudinal Pathology Data
Florian R. Schroeck, MD, MS1; Olga V. Patterson, PhD2; Patrick Alba, BA2; Scott L. DuVall, PhD2; Brenda Sirovich, MD, MS3; Douglas J. Robertson, MD, MPH3; John D. Seigne, MBBS4; Philip P. Goodney, MD, MS3
1White River Junction VA Medical Center, White River Junction, VT, and Section of Urology and Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH; 2VA Salt Lake City Health Care System and the Division of Epidemiology, University of Utah, Salt Lake City, UT; 3White River Junction VA Medical Center, White River Junction, VT; 4Section of Urology and Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH
8:16 am - 8:24 am 58. Characterizing the Costs of Complications after Cystectomy
Matthew Mossanen, MA; Ross Krasnow, MD; Matthew Ingham, MD; Mark Preston, MD; MPH; Albert Ha, MD; Stuart Lipsitz, ScD; Adam S. Kibel, MD; Steven L. Chang, MD, MS
Harvard University - Brigham and Women's Hospital, Boston, MA
8:24 am - 8:32 am 59. Determinants of Active Surveillance in Patients with Small Renal Masses: A National Cancer Database (NCDB) Study
Kevin A. Nguyen, MS; Jamil S. Syed, MD; Brian Shuch, MD; Michael Leapman, MD
Yale School of Medicine, New Haven, CT
8:32 am - 8:40 am 60. Perioperative Outcomes of Aspirin Use in Partial Nephrectomy
Matthew D. Ingham, MD; Ross E. Krasnow, MD; Matthew Mossanen, MD; Ye Wang, PhD; Adam B. Althaus, MD; Steven L. Chang, MD, MS
Brigham and Women's Hospital, Harvard Medical School, Boston, MA
8:40 am - 8:48 am 61. Diagnosis and Management of Urachal Remnants in a Tertiary Care Center
Marc D. Calabrese, MD1; Kristian D. Stensland, MD1; Jared Schober, MD1; Usama Siddique, BS2; Ariel K. Fredrick, MD1; Jennifer Broder, MD1; Alireza Moinzadeh, MD1
1Lahey Hospital and Medical Center, Burlington, MA; 2Tufts University School of Medicine, Boston, MA
8:48 am - 8:56 am 62. IMP3 Positivity Predicts Metastatic-Free Survival in a Contemporary Cohort of Patients with Renal Cell Cancer
Alexander Miller, BA; Zhong Jiang, MD; Kristine Cornejo, MD; Tong Sun, MD; Mitchell Sokoloff, MD; Jennifer K. Yates, MD
University of Massachusetts, Worcester, MA
8:56 am - 9:04 am 63. The Association between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer
Emily C. Serrell, MS1; Stephen T. Ryan, MD2; Patrick Karabon, MS3; Gregory J. Mills, BA1; Moritz H. Hansen, MD1; Matthew Hayn, MD2; Mani Menon, MD3; Quoc Dien-Trinh, MD4; Firas Abdollah, MD3; Jesse D. Sammon, DO1
1Center for Outcomes Research and Evaluation, Portland, ME; 2Maine Medical Center, Portland, ME; 3Henry Ford Health System, Detroit, MI; 4Brigham and Women's Hospital, Boston, MA
9:04 am - 9:12 am 64. Adjuvant Chemotherapy in the Treatment of Lymph Node Positive Squamous Cell Carcinoma of the Penis: Analysis of the National Cancer Database
Valary T. Raup, MD; Nawar Hanna, MD; Manuel Ozambela, MD; Julie Szymaniak, MD; Jairam Eswara, MD
Brigham and Women's Hospital, Harvard Medical School, Boston, MA
9:12 am - 9:20 am 65. Survival Analysis of Cytoreductive Nephrectomy in the Elderly
Ariel K. Fredrick, MD; Kristian D. Stensland, MD; Jared Schober, MD; Marc D. Calabrese, MD; David Canes, MD; Alireza Moinzadeh, MD
Lahey Hospital and Medical Center, Burlington, MA
9:20 am - 9:28 am 66. Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy
Philip J. Cheng, MD; Valerie Haines, RN, MSN; Jill Steinberg, RN, MPH; Peter A. Najjar, MD, MBA; Graeme S. Steele, MD; Quoc-Dien Trinh, MD; Jairam R. Eswara, MD; Steven L. Chang, MD, MS; Adam S. Kibel, MD; Matthias F. Stopfkuchen-Evans, MD; Mark A. Preston, MD, MPH
Brigham and Women's Hospital, Boston, MA
9:30 am - 10:00 am Panel VI: Management of Renal Masses and Expanded Use of Minimally Invasive Surgery
Moderator: Steven L. Chang, MD, MS
Panelists: Andrew A. Wagner, MD; Patrick Kenney, MD; David Canes, MD
10:00 am- 10:30 am COFFEE BREAK, VISIT EXHIBITS
Fontaine
10:30 am -11:15 am LEADBETTER LECTURE
Westmount & Outremont

Beyond Urodynamics: Why All Urologists Should Care About Neurogenic Bladder Research
John T. Stoffel, MD
University of Michigan, Burlington, MI
11:15 am - 12:00 pm PRESIDENTIAL ADDRESS
Westmount & Outremont

Do What You Love and Love What You Do
Paula B. Bellin, MD
UMass Memorial Medical Center, Worcester, MA
12:00 pm - 12:30 pm STATE OF THE ART LECTURE III: Role of Robotic Surgery in Benign Disease
Westmount & Outremont
Alireza Moinzadeh, MD
Lahey Clinic, Burlington, MA
12:30 pm - 2:00 pm LUNCH SYMPOSIUM (Non-CME)
Verdun - Lasalle
2:00 pm - 2:30 pm AUA GUIDELINES UPDATE
Westmount & Outremont
2:30 pm - 3:10 pm SCIENTIFIC SESSION VII: Trauma/Reconstruction/Transplant
Westmount & Outremont (6 minute presentation, 2 minute discussion)
Moderators: William Bihrle, MD; Jerilyn M. Latini, MD
2:30 pm - 2:38 pm 67. Urethroplasty Outcomes for an Algorithmic Approach for Fossa Navicularis Urethral Strictures
Mark Broadwin, BA, MS1; Alex J. Vanni, MD2
1Tufts University School of Medicine, Boston, MA; 2Lahey Hospital and Medical Center, Burlington, MA
2:38 pm - 2:46 pm 68. Change in Stricture Length Following Urethral Rest
Madeline Cancian, MD, Kennon Miller, MD
Brown University, Providence, RI
2:46 pm - 2:54 pm 69. Optimizing Waiting Duration for Renal Transplants in the Setting of Renal Malignancy: Is Two Years Too Long to Wait?
Kevin A. Nguyen, MS1; Jamil S. Syed, MD1; Randy Luciano, MD, PhD1; Brian Shuch, MD1; Srinivas Vourganti, MD2
1Yale School of Medicine, New Haven, CT; 2Rush University Medical Center, Chicago, IL
2:54 pm - 3:02 pm *70. Effect of Urethroplasty on Anxiety and Depression
Jared P. Schober, MD1; Kristian D. Stensland, MD1; Benjamin N. Breyer, MD2; Bradley A. Erickson, MD3; Jeremy B. Myers, MD4; Brian B. Voelzke, MD5; Jill C. Buckley, MD6; Alex J. Vanni, MD1
1Lahey Hospital and Medical Center, Burlington, MA; 2University of California, San Francisco, CA; 3University of Iowa, Iowa City, IA; 4University of Utah, Salt Lake City, UT; 5University of Washington, Seattle, WA; 6University of California, San Diego, CA
3:02 pm - 3:10 pm 71. Retrograde Urethrogram Findings and Urethral Stricture Recurrence
Madeline Cancian, MD; Atip Chatsudthipong, MD; Kennon Miller, MD
Brown University, Providence, RI
3:10 pm - 3:45 pm PANEL VII: Role of Robot in Microsurgery and Infertility: Debate
Westmount & Outremont
Panelists: Cigdem Tanrikut, MD; Andrew McCullough, MD
3:45 pm ADJOURN
6:00 pm - 9:00 pm PRESIDENT'S DINNER AND MUSEUM RECEPTION
Montreal Museum of Fine Arts


* Max K. Willscher Award Eligible